Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)

Market Cap	23.58B
Revenue (ttm)	1.30B
Net Income (ttm)	144.88M
Shares Out	446.90M
EPS (ttm)	0.36
PE Ratio	96.73
Forward PE	90.63
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,817,020
Average Volume	1,937,097
Open	33.46
Previous Close	34.38
Day's Range	33.46 - 38.20
52-Week Range	7.07 - 38.80
Beta	0.09
RSI	63.82
Earnings Date	Mar 25, 2026

About HKG:2315

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally. It operates through five segments: Gene-editing services, Pre-clinical pharmacology and efficacy evaluation, Animal models selling, Antibody development, and Innovative drugs development. The Gene-editing services segment provides the customized gene editing services based on animals as well as c...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 1,117
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2315

Financial Performance

Financial numbers in CNY